Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Topical spironolactone effectively treats hair loss in women.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Topical spironolactone effectively treats hair loss in women.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Men's thigh hair grows longer and has a longer growth cycle than women's, but arm hair growth is similar between genders.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.